Binder Groesswang and Willkie Farr & Gallagher have advised Ardian, an independent private investment company, on the sale of ESIM Chemicals to an affiliate of Sun European Partners, LLP. The buyer reportedly was represented by Sidley Austin and Herbst Kinsky.
The transaction is expected to close in the first half of 2018.
Ardian acquired the Exclusive Synthesis (ES) and Maleic Anhydride Intermediates & Specialties (IM) business from DPx Holdings B.V. in 2015. Over the past three years, the company has supported its management team's efforts to combine ES and IM and to build a stand-alone corporate organization and infrastructure with departments for research and development, sales and marketing, finance and controlling, and IT.
The Willkie Farr team included Partners Maximilian Schwab, Mario Schmidt, Jan Wilms, and Susanne Zuhlke, and Associates Stefan Buhrle, Lukas Nein, Ali Kilic, Laura Pfirrmann, Christopher Clerihew, and Philipp Heuser.
The Binder Groesswang team included Partners Thomas Schirmer, Markus Uitz, Christian Wimpissinger, Ivo Rungg, Johannes Barbist, Angelika Pallwein-Prettner, and Christine Dietz, Senior Associates Sabine Apfl-Trompeter and Clemens Willvonseder, and Associates Lukas-Sebastian Swoboda, Michael Delitz, Arne Greiner, and Artan Duraku.
Herbst Kinsky did not reply to our inquiries on the matter.
